These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 6319669)
21. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor. Johnson GJ; Dunlop PC; Leis LA; From AH Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295 [TBL] [Abstract][Full Text] [Related]
22. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [TBL] [Abstract][Full Text] [Related]
23. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition. Patscheke H; Hornberger W; Zehender H Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038 [TBL] [Abstract][Full Text] [Related]
24. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate. Hornberger W; Patscheke H Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034 [TBL] [Abstract][Full Text] [Related]
25. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Fonlupt P; Croset M; Lagarde M Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628 [TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235 [TBL] [Abstract][Full Text] [Related]
27. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Le Breton GC; Venton DL; Enke SE; Halushka PV Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066 [TBL] [Abstract][Full Text] [Related]
30. Effects of 2-indolecarbohydrazides on thromboxane synthetase activity and on in vitro and ex vivo blood platelet aggregation. New selective inhibitors. Monge A; Erro A; Parrado P; Font M; Aldana I; Rocha E; Fernandez-Alvarez E Arzneimittelforschung; 1986 Aug; 36(8):1184-6. PubMed ID: 3096343 [TBL] [Abstract][Full Text] [Related]
31. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Okwu AK; Mais DE; Halushka PV Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280 [TBL] [Abstract][Full Text] [Related]
32. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599 [TBL] [Abstract][Full Text] [Related]
33. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429 [TBL] [Abstract][Full Text] [Related]
34. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors. Mais DE; Liel N; Halushka PV Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838 [TBL] [Abstract][Full Text] [Related]
35. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation. Heinroth I; Block HU; Mest HJ Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555 [TBL] [Abstract][Full Text] [Related]
36. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand. Zehender H; Witte EC; Wolff HP; Patscheke H Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585 [TBL] [Abstract][Full Text] [Related]
37. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816 [TBL] [Abstract][Full Text] [Related]
38. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus. Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665 [No Abstract] [Full Text] [Related]
39. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2]. Mazurov AB; Leĭtin VL; Repin VS Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262 [TBL] [Abstract][Full Text] [Related]
40. Preparation and biological evaluation of a potential photoaffinity label for the prostaglandin H2/thromboxane A2 receptor. Arora SK; Kattelman EJ; Lim CT; Le Breton GC; Venton DL J Med Chem; 1987 May; 30(5):918-24. PubMed ID: 2952799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]